Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

The tricarboxylic acid (TCA) cycle, also known as the citric acid cycle or Krebs cycle, is the central hub of cellular energy metabolism, and accurate quantification of its intermediates is essential for research into mitochondrial function, cancer metabolism, and metabolic disease. Professional determination of TCA cycle intermediates relies on advanced LC-MS/MS and HPLC platforms to deliver sensitive, reproducible measurement of citrate, isocitrate, alpha-ketoglutarate, succinate, fumarate, malate, and related metabolites. This article provides a comprehensive technical overview of sample requirements, analytical methods, quality control, and applications of TCA cycle intermediate quantification.

Technical Overview

The tricarboxylic acid (TCA) cycle, also referred to as the citric acid cycle or Krebs cycle, is a series of enzyme-catalyzed reactions in the mitochondrial matrix that oxidizes acetyl-CoA to carbon dioxide while generating NADH, FADH2, and GTP for oxidative phosphorylation. Beyond energy production, the cycle supplies biosynthetic precursors for amino acids, nucleotides, heme, and lipids, and acts as a metabolic sensor linking nutrient availability to cellular signaling. Consequently, the intracellular concentrations of TCA cycle intermediates directly reflect mitochondrial functional status and whole-cell metabolic state.

Quantitative determination of these intermediates is analytically demanding for several reasons: the analytes are small, highly polar organic acids that are poorly retained on conventional reversed-phase columns; most lack strong chromophores, limiting UV detection sensitivity; several intermediates, such as oxaloacetate and succinyl-CoA, are chemically unstable and rapidly degrade or interconvert during handling; and endogenous concentrations span from low nanomolar to low millimolar levels depending on the tissue. A robust workflow therefore combines rapid metabolic quenching, low-temperature extraction, isotope-labeled internal standard correction, and LC-MS/MS detection in multiple reaction monitoring (MRM) mode, enabling simultaneous absolute quantification of the core intermediates in a single injection with limits of quantification in the low nanomolar range.

Testing Samples

Because TCA cycle intermediates turn over within seconds, appropriate sample collection and quenching are decisive for data quality. The following sample types are routinely accepted:

Animal Tissues

Liver, heart, skeletal muscle, brain, kidney, and tumor tissues (typically 50-200 mg wet weight) should be excised rapidly, clamp-frozen in liquid nitrogen or on dry ice, and stored at -80°C until extraction. Freeze-clamping within seconds of excision prevents post-ischemic drift of metabolite concentrations.

Cultured Cells

Adherent or suspension cells (1-10 million cells per sample) are rapidly washed with cold isotonic saline to remove medium components, quenched with pre-cooled methanol/water, and collected on dry ice. Cell number or total protein should be recorded to allow normalization of results.

Biofluids

Plasma, serum, urine, and cerebrospinal fluid are collected using standard clinical protocols, immediately frozen, and shipped on dry ice. Urinary results are typically normalized to creatinine concentration.

Plant and Microbial Samples

Leaves, roots, seeds, fruits, isolated chloroplasts or mitochondria, bacteria, yeast, and fermentation broth can all be analyzed. Microbial cultures require fast filtration or cold centrifugation quenching to halt metabolism before extraction.

Other Matrices

Isolated organelle preparations, cell culture media, food and beverage matrices, and environmental samples can be accommodated with appropriate method adaptation and validation.

Testing Items

The core panel of TCA cycle intermediates available for quantitative determination typically includes the following analytes:

  • Citric acid (citrate) - the first intermediate formed by citrate synthase; a central reporter of mitochondrial acetyl-CoA flux and lipogenic citrate export.
  • cis-Aconitic acid - the transient intermediate of aconitase; its accumulation indicates aconitase inhibition by oxidative stress or fluorocitrate.
  • Isocitric acid (isocitrate) - the substrate of isocitrate dehydrogenase (IDH); the citrate-to-isocitrate ratio reports aconitase activity.
  • alpha-Ketoglutaric acid (2-oxoglutarate) - a hub metabolite linking the cycle to amino acid transamination, nitrogen metabolism, and dioxygenase signaling.
  • Succinic acid (succinate) - accumulates under hypoxia and succinate dehydrogenase (SDH) deficiency; recognized as an inflammatory signal and oncometabolite.
  • Fumaric acid (fumarate) - accumulates in fumarate hydratase-deficient tumors and acts as an endogenous electrophilic stress mediator.
  • L-Malic acid (malate) - participates in the malate-aspartate shuttle, the glyoxylate shunt in plants and microbes, and anaplerotic refilling.
  • Oxaloacetic acid (oxaloacetate) - chemically unstable; usually determined by rapid enzymatic endpoint assay or reported semi-quantitatively.

Extended panels can include pyruvic acid, lactic acid, acetyl-CoA, succinyl-CoA, adenosine nucleotides, NAD+/NADH, and oncometabolites such as 2-hydroxyglutarate, enabling integrated analysis of glycolysis, the TCA cycle, and oxidative phosphorylation within a single study.

Testing Methods

Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

LC-MS/MS is the method of choice for simultaneous quantification of multiple intermediates. Polar metabolites are separated on hydrophilic interaction chromatography (HILIC), ion-exclusion, or mixed-mode columns and detected by negative-mode electrospray ionization with optimized MRM transitions for each analyte. Stable isotope-labeled internal standards, such as uniformly 13C-labeled analogs, compensate for matrix effects and extraction losses, delivering accuracy typically within plus or minus 15% and lower limits of quantification in the low ng/mL range.

High-Performance Liquid Chromatography (HPLC)

HPLC with UV detection at approximately 210 nm, either directly on an ion-exclusion column or after pre-column derivatization, provides a cost-effective option for analytes present at higher concentrations, such as citrate and malate in fruit juices and fermentation broths.

Gas Chromatography-Mass Spectrometry (GC-MS)

GC-MS following silylation or esterification derivatization offers high chromatographic resolution and integrates well with untargeted metabolomics workflows in which the same extract is profiled across multiple metabolite classes.

Ion Chromatography (IC)

Ion chromatography with suppressed conductivity or coupled MS detection excels at separating organic acid anions in complex ionic matrices without derivatization, and is particularly useful for fermentation monitoring.

Enzymatic Assays

Coupled enzymatic assays that monitor NADH oxidation at 340 nm, using systems based on citrate lyase, malate dehydrogenase, or succinate dehydrogenase, provide high analyte specificity and are ideal for single-analyte validation, plate-reader screening, and clinical chemistry settings.

Sample Preparation Workflow

A typical workflow comprises rapid quenching in liquid nitrogen or cold 80% methanol; homogenization and protein precipitation using cold methanol/water/formic acid or perchloric acid followed by potassium hydroxide neutralization; addition of isotope-labeled internal standards before extraction; centrifugation and supernatant collection; optional drying and reconstitution; LC-MS/MS analysis; and quantification against matrix-matched calibration curves with quality control samples at low, medium, and high concentrations.

Applications

  • Cancer metabolism research: identification of IDH mutation-driven 2-hydroxyglutarate production, SDH- and fumarate hydratase-deficient tumor signatures, and evaluation of metabolic reprogramming targets.
  • Mitochondrial medicine: diagnosis and mechanistic study of mitochondrial encephalomyopathies, respiratory chain defects, and mitochondrial toxicity induced by drugs such as statins, antiretrovirals, and biguanides.
  • Inborn errors of metabolism: screening and longitudinal follow-up of organic acidurias, including fumarase deficiency, alpha-ketoglutarate dehydrogenase deficiency, and combined D/L-2-hydroxyglutaric aciduria.
  • Metabolic disease research: assessment of citrate export and de novo lipogenesis, anaplerotic flux, and insulin resistance in diabetes, obesity, and nonalcoholic fatty liver disease.
  • Plant science: studies of Crassulacean acid metabolism, aluminum tolerance via citrate exudation, fruit acidity in breeding programs, and post-harvest physiology.
  • Industrial biotechnology: monitoring organic acid production by engineered microbial strains and supporting process control in industrial fermentation.
  • Exercise physiology and sports science: quantifying anaplerotic flux, malate-aspartate shuttle activity, and fatigue-associated succinate accumulation in skeletal muscle.
  • Food quality control: determination of citric, malic, fumaric, and succinic acid contents in juices, wines, dairy products, and acidulant additives.

FAQ

Why is rapid quenching so important?

TCA cycle intermediates turn over within seconds. Slow freezing allows residual enzymatic activity to alter concentrations dramatically; freeze-clamping or immediate cold-solvent quenching is therefore mandatory for meaningful quantitative results.

Can oxaloacetate be accurately quantified?

Oxaloacetate is chemically unstable and spontaneously decarboxylates to pyruvate. It is generally reported semi-quantitatively by LC-MS/MS or determined precisely by an enzymatic endpoint assay performed immediately after extraction.

What sample quantities are required?

As a general guideline: 50-200 mg of tissue, 1-10 million cultured cells, or 100-200 microliters of biofluid per analyte panel. Smaller inputs can often be accommodated using microflow or capillary LC-MS systems.

How should samples be stored and shipped?

Samples should be snap-frozen immediately after collection, stored at -80°C, shipped on dry ice with temperature monitoring, and never subjected to repeated freeze-thaw cycles, which cause significant degradation of labile intermediates.

What sensitivity and turnaround time can be expected?

Lower limits of quantification typically range from 1 to 50 ng/mL depending on the analyte, with linear ranges covering three to four orders of magnitude. Standard projects are completed within 10-15 working days, including extraction, instrument analysis, and delivery of a report containing absolute concentrations, quality control metrics, and statistical summaries.